Visit COVID-19 resources

[Skip to Content]

Latest Papers

Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ – (Eye Journal AOP)

Apr 22
2016

Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ Eye advance online publication, April 22 2016. doi:10.1038/eye.2016.82 Authors: D A Godefrooij, G A de Wit, M J Mangen & R P L Wisse

  • 22 April 2016

Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’ – (Eye Journal AOP)

Apr 22
2016

Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’ Eye advance online publication, April 22 2016. doi:10.1038/eye.2016.83 Authors: D Călugăru & M Călugăru

  • 22 April 2016

Response to: ‘Comment on Central retinal vein occlusion: modifying current treatment protocols’ – (Eye Journal AOP)

Apr 22
2016

Response to: ‘Comment on Central retinal vein occlusion: modifying current treatment protocols’ Eye advance online publication, April 22 2016. doi:10.1038/eye.2016.84 Authors: M Ashraf, A A R Souka & R P Singh

  • 22 April 2016

The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group – (Eye Journal AOP)

Apr 15
2016

The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group Eye advance online publication, April 15 2016. doi:10.1038/eye.2016.72 Authors: S J Talks, R Gupta & S Buckley

  • 15 April 2016

The translaminar pressure difference as an index for neurotoxic burden in the anterior part of the optic nerve – (Eye Journal AOP)

Apr 15
2016

The translaminar pressure difference as an index for neurotoxic burden in the anterior part of the optic nerve Eye advance online publication, April 15 2016. doi:10.1038/eye.2016.73 Authors: P Wostyn, V De Groot, D Van Dam, K Audenaert & P P De Deyn

  • 15 April 2016